Site icon pharmaceutical daily

Global Clinical Trial Supplies Markets 2023-2028 by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.


The global clinical trial supplies market is projected to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9%.

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.

Factors such as the increasing number of clinical trials, growing product pipeline, and increasing decentralization of clinical trials are likely to have a positive impact on market growth.

The logistics and distribution segment held the dominant share in 2022

Based on services, the global clinical trial supplies market is segmented into pathogen component, adjuvant emulsions, particulate adjuvants, saponin-based adjuvants and other adjuvants. The adjuvant emulsions segment held a dominant share in the market in 2022. Extensive use of adjuvant emulsions in COVID-19 & other infectious diseases and the rising prevalence of contagious diseases are likely to have positive impact on the growth of the market.

Phase II segment accounted for the largest share of the phase segment in 2022

Based on phase, the clinical trial supplies market is segmented into phase I, phase II, phase III, phase IV, BA/BE studies. In 2022, the phase II segment accounted for the largest share of the clinical trial supplies market. The segment held the dominant share in the market owing to various factors such as increasing the number of registration in clinical trials and the rising R&D investment by pharmaceutical and biotechnologies company for new cancer drug development.

Asia-Pacific region is likely to grow at a faster pace

Asia-Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by the increasing number of registered clinical trials.

The increasing decentralization of clinical trials from China, India, and Japan due to presence of prominent players are engaged in providing services for clinical trial, supports market growth in the Asia-Pacific.

Key Attributes:

Report Attribute Details
No. of Pages 328
Forecast Period 2023 – 2028
Estimated Market Value (USD) in 2023 $3.9 Billion
Forecasted Market Value (USD) by 2028 $6.3 Billion
Compound Annual Growth Rate 9.9%
Regions Covered Global

Premium Insights

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Company Profiles

Key Market Players

Other Players

For more information about this report visit https://www.researchandmarkets.com/r/ko8c8q

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version